Polygenic Risk Scores: A game-changer for disease prevention and personalised healthcare.

/
Polygenic Risk Scores: A game-changer for disease prevention and personalised healthcare.

Polygenic Risk Scores (PRS) are transforming the way we predict, prevent, and manage common diseases like cancer, cardiovascular disease, and diabetes. By analysing thousands of genetic variants, PRS provides a powerful tool for identifying individuals at higher risk, enabling earlier interventions and more personalised healthcare strategies. Now, with the integration of Allelica PREDICT and AGRF’s high-quality genotyping services, researchers and clinicians have access to cutting-edge PRS analysis that strengthens primary care, enhances public health initiatives, and supports groundbreaking medical research.

Read More

Partnership to Drive Innovation in Genomic Science

/
Partnership to Drive Innovation in Genomic Science

An exciting partnership between AGRF (the Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities.

The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field.

Read More

AGRF Partners with Integrated Sciences to Offer Cutting-Edge Epigenetic Services with EpiCypher CUT&RUN and CUT&Tag Technologies→

/
AGRF Partners with Integrated Sciences to Offer Cutting-Edge Epigenetic Services with EpiCypher CUT&RUN and CUT&Tag Technologies

AGRF (Australian Genome Research Facility Ltd) and Integrated Sciences are excited to announce a new partnership that will bring advanced genomics capabilities to researchers across Australia and New Zealand. This collaboration will enable AGRF’s Advanced Genomics group to offer cutting-edge epigenetic services utilising EpiCypher’s CUT&RUN and CUT&Tag technologies.

Read More

AGRF Expands Olink® Platform with Signature Q100, Boosting Biomarker Discovery and Prognosis Capabilities

/
AGRF Expands Olink® Platform with Signature Q100, Boosting Biomarker Discovery and Prognosis Capabilities

Media Release

AGRF is thrilled to announce the expansion of its Olink® fleet with the addition of the Olink Signature Q100. Funded by The Kids Research Institute (The Kids) in Perth, the platform joins our certified Olink Explore HT and Explore 3072 workflows and will allow us to run the Olink Target 96 and 48 workflows, enabling researchers with both absolute and relative quantitative proteomic data, driving the identification and validation of biomarkers from early discovery to implementation and disease risk prediction.

Read More

Professor Melanie Bahlo joins AGRF Board

/
Professor Melanie Bahlo joins AGRF Board

We are delighted to announce that Professor Melanie Bahlo joined AGRF’s board. Melanie is a renowned expert in medical biology, with an impressive career dedicated to advancing research in health and ageing. Melanie currently serves as a Professor at the Walter and Eliza Hall Institute (WEHI), where she leads the "Healthy Development and Ageing" theme, underlining her commitment to impactful research in this critical field.

Read More

Milestone Achievement For Paediatric Cancer Research

/
Milestone Achievement For Paediatric Cancer Research

In an exciting step forward for children’s cancer research, the Australian Cancer Research Foundation (ACRF) has awarded a $2 million grant to Children’s Cancer Institute.  The grant will advance the initiation of their Spatial Immune-oncology Research program, aiming to unlock the potential of immunotherapies specifically tailored for childhood cancer. A key partnership with AGRF will introduce our Olink technology for in-depth protein analysis, unlocking new possibilities in paediatric cancer research.

Read More

AGRF: Bringing Olink® Next Generation Proteomic Technology to Australia.

/
AGRF: Bringing Olink® Next Generation Proteomic Technology to Australia.

AGRF is thrilled to announce the introduction of the Olink Explore high throughput platform to our fleet of cutting-edge technologies, bringing the most advanced proteomic technology to Australia and positioning AGRF as a truly multi-omics destination. This strategic move promises to be a game changer in precision medicine, offering researchers a full multi-omics profile of patient and biobank samples.

Read More

Congratulations Dr. Benjamin Nash: Winner of the 2023 PacBio Revio HiFi Sequencing Grant Opportunity

/
Congratulations Dr. Benjamin Nash: Winner of the 2023 PacBio Revio HiFi Sequencing Grant Opportunity

We are thrilled to announce that Dr Benjamin Nash has been named as the recipient of the 2023 PacBio ANZ Revio HiFi SMRT Grant! Ben’s project, titled “Precision medicine in inherited retinal dystrophies (IRDs) using long read sequencing.” has captured our attention and admiration and we are delighted to be working with Ben and his team.

Read More

A Stellar Achievement: Dr. Kirk Jensen Joins NASA’s elite STAR Program

/
A Stellar Achievement: Dr. Kirk Jensen Joins NASA’s elite STAR Program

As we conclude National Science Week 2023, we are delighted to share a truly exceptional achievement that resonates with the spirit of innovation and inspiration.  It is with great excitement that we can reveal the news of Dr Kirk Jensen’s selection into NASA’s prestigious STAR (Space Technology Advanced Research) program.  This achievement marks a significant milestone in Kirk’s career, reflecting his brilliance and commitment to excellence in Single Cell and Spatial Biology.

Read More

AGRF Continues to Raise the Bar for Genomic Sequencing in Australia

/
AGRF Continues to Raise the Bar for Genomic Sequencing in Australia

Media Release

The latest in highly accurate long-read sequencing technology has arrived at AGRF. First in Australia and the region, the PacBio Revio offers dramatic improvements in the production of high precision HiFi reads at lower sequencing costs and symbolises an important shift in the acceleration of biological understanding.

“The answers people are looking for are often locked up deep inside of our genomes. This system will enable scientists to tackle their biggest questions, no matter what fields they are exploring. We are thrilled to be the first in Australia to implement the Revio and support clients at an affordability that has not been possible before.”

Dr Cath Moore, Chief Scientific Officer - AGRF

Read More

AGRF: Setting a New Standard for Genomic Sequencing in Australia

/
AGRF: Setting a New Standard for Genomic Sequencing in Australia

Media Release

Australian Genome Research Facility (AGRF) has expanded its state-of-the-art genomic sequencing line-up with the arrival of Illumina’s most powerful sequencing instrument to-date, the NovaSeq™ X Plus. AGRF is Australia’s premier genomics service provider, proudly supporting the genomics community in Australia and beyond for the past 25 years.

“We continue to provide access to cutting edge technology for our clients and partners and are thrilled to be the first in Australia and amongst the first in the world to introduce this incredible system” says AGRF Chief Executive Officer, Joe Baini.

Read More